Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions

被引:0
作者
Laurent Fauchier
Arnaud Bisson
Alexandre Bodin
机构
[1] Université François Rabelais,Service de Cardiologie, Centre Hospitalier Universitaire Trousseau Et Faculté de Médecine
来源
BMC Medicine | / 21卷
关键词
Heart failure with preserved ejection fraction; Atrial fibrillation; SGLT2 inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
Atrial fibrillation (AF) and heart failure (HF) are frequently associated and can be caused or exacerbated by each other through different mechanisms. AF is particularly common in patients with heart failure with preserved ejection fraction (HFpEF) defined as left ventricular ejection fraction (LVEF) ≥ 50%, with a prevalence ranging around 40–60%.
引用
收藏
相关论文
共 112 条
[1]  
Hindricks G(2021)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Eur Heart J 42 373-498
[2]  
Potpara T(2021)2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 42 3599-3726
[3]  
Dagres N(2021)Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study BMC Med 19 179-4284
[4]  
Arbelo E(2018)Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry Eur Heart J 39 4277-574
[5]  
Bax JJ(2017)Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction JACC Heart Fail 5 565-204
[6]  
Blomström-Lundqvist C(2020)The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 22 195-2500
[7]  
McDonagh TA(2017)Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction J Am Coll Cardiol 70 2490-6539
[8]  
Metra M(2022)Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER J Am Coll Cardiol S0735–1097 06529-1140
[9]  
Adamo M(2022)Heart failure with improved ejection fraction: insight into the variable nature of left ventricular systolic function Int J Environ Res Public Health 19 14400-1461
[10]  
Gardner RS(2019)Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS) Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 387 1138-1098